Heska and FUJIFILM in an Exclusive Arrangement
LOVELAND, Colo., Nov. 5 / -- Heska Corporation (NASDAQ:HSKA)("Heska"), a leading provider of advanced diagnostic and specialty products to veterinarians, today announced the introduction of the Heska(R) Dri-Chem 4000 Veterinary Clinical Chemistry Analyzer by FUJIFILM (the "Dri-Chem 4000"). The Dri-Chem 4000 is the latest in a series of new diagnostic instruments Heska has launched this year.
FUJIFILM Corporation ("FUJIFILM") has entered into an exclusive agreement to supply Heska with the Dri-Chem 4000 and affiliated consumables for the veterinary field in the North American market. Heska and FUJIFILM collaborated on the specifications and final development of the Dri-Chem 4000 system.
The Dri-Chem 4000 is a robust instrument that uses dry slide technology which has a long track record of proven performance. In addition to multiple test panels, the instrument has the flexibility to conduct individual tests. The Dri-Chem 4000 has a broader menu of tests available than Heska's previous chemistry instrument offering.
"FUJIFILM has built a stellar brand around the world for quality technology and products," commented Robert Grieve, Chairman and CEO of Heska. "We are excited to offer our customers a new Heska product with the capabilities of the Dri-Chem 4000 and the FUJIFILM reputation behind it."
"In considering how we could expand our business in the veterinary market, we were struck by Heska's reputation for excellent customer support and the value of the Heska brand. We appreciate Heska's collaborative efforts to optimize the Dri-Chem 4000 system for veterinary use," said Yuzo Toda, Corporate Vice President of FUJIFILM. "As we have worked with Heska, we have come to appreciate that our companies share similar values and a common vision for success in the veterinary market. We anticipate this is the mere beginning of a successful long-term strategic relationship. We are excited about investigating other areas in which we may collaborate with Heska in the future."
Heska Corporation (NASDAQ:HSKA) sells advanced veterinary diagnostic and other specialty veterinary products. Heska's state-of-the-art offerings to its customers include diagnostic and monitoring instruments and supplies as well as single use, point-of-care tests, vaccines and pharmaceuticals. The company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians. For further information on Heska and its products, visit the company's website at http://www.heska.com/.
CONTACT: Jason Napolitano, Executive Vice President & CFO of Heska Corporation, +1-970-493-7272, ext. 4105
Web site: http://www.heska.com/